Kanchan Kumari and Sandip K Mishra*
Cancer Biology Laboratory, Department of Cancer Biology, Institute of Life Sciences (Department of Biotechnology, Govt of India), Bhubaneswar, Odisha, India
*Corresponding Author: Sandip K Mishra, Scientist-F, Cancer Biology Laboratory, Department of Cancer Biology, Institute of Life Sciences, Bhubaneswar, Odisha, India.
Received: June 04, 2020; Published: June 22, 2020
The world is experiencing the outbreak of highly infectious RNA virus named COVID-19 or SARS-CoV-2 since December last year. As on 28 May 2020, World Health Organization (WHO) has reported 5,556,679 confirmed cases of COVID-19, including 351,866 deaths worldwide. Clinicians and scientists now know much about the characteristics of the virus and its effect on human health which is similar to SARC-CoV but with more serious outcomes.
Citation: Kanchan Kumari and Sandip K Mishra. “Artemisinin and its Derivatives as Repurposing Drug against COVID-19”.Acta Scientific Cancer Biology 4.7 (2020): 21-23.
Copyright: © 2020 Kanchan Kumari and Sandip K Mishra. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.